» Articles » PMID: 25914788

Helicobacter Pylori Vs Coronary Heart Disease - Searching for Connections

Overview
Journal World J Cardiol
Date 2015 Apr 28
PMID 25914788
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

In this review, we discussed the findings and concepts underlying the potential role of Helicobacter pylori (H. pylori) infections in the initiation, development or persistence of atherosclerosis and coronary heart disease (CHD). This Gram-negative bacterium was described by Marshall and Warren in 1984. The majority of infected subjects carries and transmits H. pylori with no symptoms; however, in some individuals these bacteria may cause peptic ulcers, and even gastric cancers. The widespread prevalence of H. pylori infections and the fact that frequently they remain asymptomatic may suggest that, similarly to intestinal microflora, H. pylori may deliver antigens that stimulate not only local, but also systemic inflammatory response. Recently, possible association between H. pylori infection and extragastric disorders has been suggested. Knowledge on the etiology of atherosclerosis together with current findings in the area of H. pylori infections constitute the background for the newly proposed hypothesis that those two processes may be related. Many research studies confirm the indirect association between the prevalence of H. pylori and the occurrence of CHD. According to majority of findings the involvement of H. pylori in this process is based on the chronic inflammation which might facilitate the CHD-related pathologies. It needs to be elucidated, if the infection initiate or just accelerate the formation of atheromatous plaque.

Citing Articles

The influence of infection on acute coronary syndrome and lipid metabolism in the Chinese ethnicity.

Fang Y, Fan C, Li Y, Xie H Front Cell Infect Microbiol. 2024; 14:1437425.

PMID: 39290976 PMC: 11405380. DOI: 10.3389/fcimb.2024.1437425.


bacterium association with atherosclerosis and other diseases.

Voronina A, Arapidi G Front Microbiol. 2024; 15:1371717.

PMID: 38650874 PMC: 11033375. DOI: 10.3389/fmicb.2024.1371717.


Helicobacter pylori components increase the severity of metabolic syndrome and its hepatic manifestations induced by a high fat diet.

Tomaszewska A, Gonciarz W, Rechcinski T, Chmiela M, Kurdowska A, Krupa A Sci Rep. 2024; 14(1):5764.

PMID: 38459219 PMC: 10923818. DOI: 10.1038/s41598-024-56308-7.


Infection: Current Status and Future Prospects on Diagnostic, Therapeutic and Control Challenges.

Elbehiry A, Marzouk E, Aldubaib M, Abalkhail A, Anagreyyah S, Anajirih N Antibiotics (Basel). 2023; 12(2).

PMID: 36830102 PMC: 9952126. DOI: 10.3390/antibiotics12020191.


Infection Induces Intestinal Dysbiosis That Could Be Related to the Onset of Atherosclerosis.

Francisco A Biomed Res Int. 2022; 2022:9943158.

PMID: 36317116 PMC: 9617700. DOI: 10.1155/2022/9943158.


References
1.
Israel D, Peek R . pathogenesis of Helicobacter pylori-induced gastric inflammation. Aliment Pharmacol Ther. 2001; 15(9):1271-90. DOI: 10.1046/j.1365-2036.2001.01052.x. View

2.
Kilic A, Onguru O, Tugcu H, Kilic S, Guney C, Bilge Y . Detection of cytomegalovirus and Helicobacter pylori DNA in arterial walls with grade III atherosclerosis by PCR. Pol J Microbiol. 2007; 55(4):333-7. View

3.
Cybulsky M . Morphing the topography of atherosclerosis: an unexpected role for PECAM-1. Arterioscler Thromb Vasc Biol. 2008; 28(11):1887-9. DOI: 10.1161/ATVBAHA.108.174029. View

4.
Sealy-Jefferson S, Gillespie B, Aiello A, Haan M, Morgenstern L, Lisabeth L . Antibody levels to persistent pathogens and incident stroke in Mexican Americans. PLoS One. 2013; 8(6):e65959. PMC: 3682951. DOI: 10.1371/journal.pone.0065959. View

5.
Ameriso S, Fridman E, Leiguarda R, Sevlever G . Detection of Helicobacter pylori in human carotid atherosclerotic plaques. Stroke. 2001; 32(2):385-91. DOI: 10.1161/01.str.32.2.385. View